» Articles » PMID: 32082127

Mechanisms of Shared Vulnerability to Post-traumatic Stress Disorder and Substance Use Disorders

Overview
Specialty Psychology
Date 2020 Feb 22
PMID 32082127
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Psychoactive substance use is a nearly universal human behavior, but a significant minority of people who use addictive substances will go on to develop an addictive disorder. Similarly, though ~90% of people experience traumatic events in their lifetime, only ~10% ever develop post-traumatic stress disorder (PTSD). Substance use disorders (SUD) and PTSD are highly comorbid, occurring in the same individual far more often than would be predicted by chance given the respective prevalence of each disorder. Some possible reasons that have been proposed for the relationship between PTSD and SUD are self-medication of anxiety with drugs or alcohol, increased exposure to traumatic events due to activities involved in acquiring illegal substances, or addictive substances altering the brain's stress response systems to make users more vulnerable to PTSD. Yet another possibility is that some people have an intrinsic vulnerability that predisposes them to both PTSD and SUD. In this review, we integrate clinical and animal data to explore these possible etiological links between SUD and PTSD, with an emphasis on interactions between dopaminergic, adrenocorticotropic, GABAergic, and glutamatergic neurobehavioral mechanisms that underlie different emotional learning styles.

Citing Articles

Impact of posttraumatic stress disorder and comorbid psychiatric conditions on suicide reattempts.

Demesmaeker A, Creupelandt C, Leroy A, Vaiva G, DHondt F Eur J Psychotraumatol. 2025; 16(1):2461435.

PMID: 39936356 PMC: 11823379. DOI: 10.1080/20008066.2025.2461435.


Does Trauma Change the Way Individuals with Post-Traumatic Stress Disorder (PTSD) Deal with Positive Stimuli?.

Pino O, Rossi M, Malvezzi M Behav Sci (Basel). 2025; 14(12.

PMID: 39767336 PMC: 11673864. DOI: 10.3390/bs14121195.


The Limbic System in Co-Occurring Substance Use and Anxiety Disorders: A Narrative Review Using the RDoC Framework.

Lin E, Veenker F, Manza P, Yonga M, Abey S, Wang G Brain Sci. 2025; 14(12.

PMID: 39766484 PMC: 11674329. DOI: 10.3390/brainsci14121285.


Oral fentanyl consumption and withdrawal impairs fear extinction learning and enhances basolateral amygdala principal neuron excitatory-inhibitory balance in male and female mice.

Downs A, Kmiec G, McElligott Z Addict Neurosci. 2025; 13.

PMID: 39742087 PMC: 11687336. DOI: 10.1016/j.addicn.2024.100182.


Using lifestyle interventions and the gut microbiota to improve PTSD symptoms.

Sugden S, Merlo G Front Neurosci. 2024; 18:1488841.

PMID: 39691626 PMC: 11649671. DOI: 10.3389/fnins.2024.1488841.


References
1.
Crombag H, Badiani A, Chan J, DellOrco J, Dineen S, Robinson T . The ability of environmental context to facilitate psychomotor sensitization to amphetamine can be dissociated from its effect on acute drug responsiveness and on conditioned responding. Neuropsychopharmacology. 2001; 24(6):680-90. DOI: 10.1016/S0893-133X(00)00238-4. View

2.
Matthews S, McGowan P . Developmental programming of the HPA axis and related behaviours: epigenetic mechanisms. J Endocrinol. 2019; 242(1):T69-T79. DOI: 10.1530/JOE-19-0057. View

3.
Wolf E, Miller M, Krueger R, Lyons M, Tsuang M, Koenen K . Posttraumatic stress disorder and the genetic structure of comorbidity. J Abnorm Psychol. 2010; 119(2):320-30. PMC: 3097423. DOI: 10.1037/a0019035. View

4.
Anisman H, Sklar L . Catecholamine depletion in mice upon reexposure to stress: mediation of the escape deficits produced by inescapable shock. J Comp Physiol Psychol. 1979; 93(4):610-25. DOI: 10.1037/h0077603. View

5.
Xie P, Kranzler H, Farrer L, Gelernter J . Serotonin transporter 5-HTTLPR genotype moderates the effects of childhood adversity on posttraumatic stress disorder risk: a replication study. Am J Med Genet B Neuropsychiatr Genet. 2012; 159B(6):644-52. PMC: 3428016. DOI: 10.1002/ajmg.b.32068. View